TYNDALL CAPITAL PARTNERS L P - Q3 2023 holdings

$505 Thousand is the total value of TYNDALL CAPITAL PARTNERS L P's 1 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

 Value Shares↓ Weighting
NewCYCLERION THERAPEUTICS INC$505,175147,712
+100.0%
100.00%
Exit00$00
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Confidential19Q2 20230.0%
ONCONOVA THERAPEUTICS INC14Q4 201921.2%
MMA CAP MGMT LLC13Q4 201999.4%
ONCONOVA THERAPEUTICS INC8Q2 201878.8%
08Q2 20150.0%
ONCONOVA THERAPEUTICS INC5Q3 201975.6%
PENDRELL CORP2Q3 201754.6%
CYCLERION THERAPEUTICS INC1Q3 2023100.0%

View TYNDALL CAPITAL PARTNERS L P's complete holdings history.

Latest significant ownerships (13-D/G)

View TYNDALL CAPITAL PARTNERS L P's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
SC 13G2023-09-05
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16

View TYNDALL CAPITAL PARTNERS L P's complete filings history.

Compare quarters

Export TYNDALL CAPITAL PARTNERS L P's holdings